Laskow-Pooley David 4
4 · Marker Therapeutics, Inc. · Filed May 26, 2022
Insider Transaction Report
Form 4
Laskow-Pooley David
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-24+80,000→ 80,000 totalExercise: $0.34Exp: 2032-05-23→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option vests on May 24, 2023, subject to the Reporting Person's continued service as a director through the vesting date.